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As healthcare continues to see both vertical and horizontal system integration, sys-
tems struggle to handle large aggregates of patient data. Big Data has aided in re-
ducing costs and increasing profits, in understanding patient risk stratification, and 
helping to determine appropriate interventions. More recently, widespread dissatis-
faction with overall healthcare costs and suboptimal quality has led to healthcare 
leaders searching for new strategies to improve. Big Data not only affords physi-
cians an epidemiological insight necessary to implement widespread change, but 
also uses retrospective insight, pattern recognition, and predictive power to offer 
direct and indirect interventions, often coupled with devices or preexisting inter-
ventions. Despite some challenges in addressing patient privacy, the paradigm shift 
from singularly managed patients and data to Big Data systems is underway. Big 
Data methodologies construe the provider as an agent within a larger community or 
population organism, one that must adapt and change to suit the needs of those it 
serves. It allows for the provision of better care, in terms of the care itself provided 
and the logic of its distribution. In the right hands, if Big Data is the face of 
healthcare’s future, it will be a humanitarian one.  
Contents 
1 Big Data: From ‘Me’ to ‘We’ .............................................................................. 198 
2 Transition to Big Data: Why Now? ..................................................................... 199 
3 Current Uses of Big Data in Device Sector ......................................................... 200 
4 Further Reforms and Opportunities in Big Data .................................................. 201 
4.1 Retrospective Insight ................................................................................. 202 
4.2 Predictive Power ........................................................................................ 202 
4.3 Data Management: Population Health ....................................................... 203 
4.4 Direct Intervention ..................................................................................... 203 
4 Implications for Healthcare & Big Data .............................................................. 204 
5 Conclusion ............................................................................................................ 205 
References ................................................................................................................... 207 
Siemens Healthineers provided valuable financial support to make this project happen. Further-
more, Marianthi N Hatzigeorgiou, a masters of health services administration candidate from 
the University of Michigan, Ann Arbor, USA, had the opportunity to intern at Siemens Healthi-
neers working on concepts for strategy consulting projects in the Healthcare Consulting and 
Transformation Services team. 
Published in: Schmid A. and Singh S. (2017), Crossing Borders - Innovation in the U.S. Health Care System, 
Schriften zur Gesundheitsökonomie, Vol. 84, Bayreuth: P.C.O.-Verlag.
Marianthi N Hatzigeorgiou 
198 
1 Big Data: From ‘Me’ to ‘We’ 
As healthcare expenditures in the United States continue to rise to levels well above the 
national inflation rate, there is a continued interest and obligation to shift towards strat-
egies and innovations that contain costs and further improve quality and outcomes. 
Though the United States spends almost twice the OECD average on healthcare spend-
ing (in USD per capita), national quality and outcome benchmarks continue to place 
well below those of less developed countries. For a country that often fashions itself as 
a world-best provider of healthcare, the growing chasm between healthcare expenditures 
and outcomes has led to the prioritization of reforms and new initiatives aimed at miti-
gating this discrepancy. As medical record keeping and documentation moves towards 
electronic platforms, large datasets are available for computational analysis, often re-
vealing patterns, trends, and associations on the individual and group level. In recent 
years, ‘Big Data’ has been a trending topic for many in the healthcare industry, allowing 
systems to utilize technological advances and opportunities in the hopes of providing 
better care, while lowering costs in the process.  
The consideration of Big Data in studying population health only began about 200 years 
ago (Siemens Healthineers, 2015). In tracking the cholera epidemic throughout London, 
John Snow’s map helped to dispel the miasma theory and locate the source of the out-
break. In in the brief span of time thereafter, there has been much improvement in trend-
ing and forecasting, largely due to technology. The application of epidemiological pur-
poses has gradually undergone a paradigm shift from individual tracking to tracking for 
population health benefits, resulting in technologies and device adaptation to allow for 
both of these activities during data collection. From a financial perspective, Big Data 
has allowed systems to identify opportunities to improve profits and reduce overhead 
(Bresnick, 2017). Electronic Medical Records (EMRs), for example, have allowed phy-
sicians and health systems to collect large quantities of data and patient information, 
which can then be used for risk stratification, to forecast patient trends, and to identify 
possible interventions.  
Considering both perspectives, Big Data has fostered an innovative methodology for 
systems: data gleaned from the individual are used to attain better understanding of the 
overall population -- and vice versa. On the one hand, Big Data is often used in the 
service of heavily-personalized medical care pathways as part of a strategy to help guide 
patient care throughout a patient’s care encounter; said strategies fall under the umbrella 
of what is commonly deemed 'population health management'. On the other, aggregated 
data is used to study disease trends for populations and to tailor community-based inter-
ventions and strategies, which may then contribute to improved population health 
through decreases in patient morbidity and mortality. Furthermore, countries with aging 
populations can use data to try and find far-reaching solutions to manage patients with 
The Big Deal with Big Data: Innovations and Perspectives for the United States 
199 
high disease burden and chronic care issues (Bresnick, 2017). But with such widespread 
opportunities for health improvement come manifold challenges in the spheres of im-
plementation and regulation, especially as pertaining to patient privacy.  
2 Transition to Big Data: Why Now? 
Widespread public dissatisfaction with overall health care costs and soaring premiums 
has led to wide-spread dissatisfaction with current reimbursement schemas. The shift 
from fee-for-service (FFS) models to value-based models of care has resulted in new 
ways to quantify success in disease management at both the individual and system level, 
contain costs, and enable equal access to and quality of care. This shift, initiated by the 
Affordable Care Act (ACA), also precipitated a shift in reimbursement methodologies 
toward an emphasis on patient outcomes, which in turn has resulted in many systems 
embracing and accepting Big Data as part of their fabric and foundation (McDonald, 
2017). Value-based reimbursement schemas, such as that targeting a reduction in 30-
day hospital readmissions, have necessitated systems to manage large swaths of patient 
data, to find trends and opportunities for improvement (Koufi, Malamateniou and 
Vassilacopoulos, 2015)(OFIs). Better understanding of upstream social and clinical con-
tributors to hospital readmission allows physicians and hospital administrators to in-
crease communication and coordination through the system; with multiple departments 
working on the same patient and tracking the same information, better care is expected 
to result from increased diligence towards patient communication, compliance, and 
oversight (Groves et al., 2013). 
Bundled payment programs offer another point of intervention for Big Data. Though 
recent administrations have further delayed widespread implementation of this cost con-
tainment strategy, most systems have implemented bundled payments in cardiology and 
orthopedics that help track outcomes and costs through the entire episode of patient care. 
Concurrent with bundled payments, multiple interventions, physicians, and services are 
tracked and tied to quality and improvement, offering further opportunities to improve 
care usage data. However, manipulation of datasets requires additional expertise and 
education, and an efficient data analytics/ information technology (IT) team remains key 
to ensuring that new payment systems are able to be implemented successfully 
(McDonald, 2017).   
Though Big Data is far from a new phenomenon for companies and strategists, the 
healthcare industry represents a large opportunity for its integration and application. Pa-
tient management and patient-centric approaches have been part of the evolutionary 
trends that healthcare in the United States has recently experienced, and the efficacy of 
these approaches stands to increase from the simultaneous adoption of Big Data strategy. 
The shift toward evidence-based medicine has caused physicians to tailor approaches 
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and interventions based on scientifically-verified results that have shown a special de-
gree of promise among patient populations (Bresnick, 2017). Big Data has allowed evi-
dence-based medicine to be collected at a systemic (and additionally, a national) level. 
As systems collect vast amounts of patient information, data may be easily manipulated 
by algorithms to identify trends, successful interventions, and cross-check strategies 
with additional comorbidities. For physicians practicing in regions of the country that 
experience high disease-burden with multiple chronic conditions (ex., rural expanses, 
many CEAC-classified counties, the Deep South), such trending allows them to track 
large groups of patients and see how different interventions influence results and quality 
(Wood, 2017). 
The overutilization of costly technologies and procedures can drive up hospital and sys-
tem spending. Global clinical decision support system markets are expected to rapidly 
rise in the coming years to help address this and other clinical inefficiencies. Such sup-
port systems can aid physicians during triaging, diagnosing, and treatment, which would 
further reduce costs and overutilization of the system. Per reporting by MarketsandMar-
kets, these global support systems are estimated to surpass $550 million by 2018, at a 
compound annual growth rate close to 10% between 2013 and 2018 (Siemens 
Healthineers, 2015). The United States is the foremost user of such systems to date, with 
over 3500 petabytes of stored data within these. Europe follows with about 2500 
petabytes, and then -- a distant third -- Japan with 400 petabytes. As countries continue 
to shift to EMRs and computerized systems with greater integrative potential, Big Data 
will be more available to them, leading to expected increases in petabytes stored. Re-
ducing costs is hypothesized as the main driver of this increased uptake, though im-
proved quality and care outcomes, aging populations, and rising disease incidence also 
play important roles in the uptake.   
3 Current Uses of Big Data in Device Sector 
The increased utilization of medical apps and smartphone technology has presented a 
new opportunity for patient tracking and Big Data management. In 2016, mobile health 
raised $1.3 billion between 622 completed deals, constituting the largest component of 
total healthcare IT virtual care (VC) funding (Mukherjee, 2017). Increased utilization of 
smartphones in emerging markets solidifies their place in future markets. Public senti-
ment is arguably in line with the data: some research has even indicated that over two-
thirds of Americans have shown favor for digital health over physical (Elias, 2015). As 
wireless technology plays an ever-larger role in the day-to-day lifestyle of a working 
American (i.e., forty-hour workweeks, heavy childcare and supplemental domestic work 
burdens), prioritizing convenience and ease-of-access will lead more systems to focus 
on tech-based platforms for patient interactions. Health smartphone apps currently have 
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the highest number of downloads of any category of application (Elias, 2015). Consum-
erization will further drive physicians to adapt a new, tech-friendly practice, at risk of 
network leakage to other practices and physicians should they fail to adapt. Regardless, 
this technological integration of medical information into the hands of patients and con-
sumers will only continue to drive innovation. A concurrent trend is unfolding in wear-
able devices; serving as a bellwether for this new trend, FDA Commissioner Scott 
Gottlieb has recently written of a 'Digital Health Innovation Plan' that would allow third-
parties to easily and rapidly certify new products that are not as ‘high risk’ as devices 
(Gottlieb, 2017). It would be expected that Big Data and patient tracking/monitoring 
apps (Fitbit, etc.) will continue to expand offerings on the market (Ventola, 2014). 
As a physician’s tools for diagnosis shift from stethoscope to smartphone, and the doc-
tor’s office waiting room shifts to the patient’s living room, other non-patient facing 
areas of medicine are also utilizing virtual platforms. One promising current technology, 
teleradiology, allows for the storage and transmission of radiological images. This Big 
Data trend comes as a way to ease the access issues radiologists and other physicians 
experience when trying to compare images, interpret images, and use images as part of 
evidence-based medicine. Picture Archiving and Communication systems (PACS) is 
just one example of an IT system used currently (Benjamin, Aradi and Shreiber, 2010). 
Teleradiology and PACS allow for improved clinical results (final reports that contain 
useful information) and business results (in scenarios of improved speed of result turn-
over, patient care, etc.). SuperPACS—a system that allows radiology group serving mul-
tiple sites having disparate PACS, research information systems (RIS), and reporting 
platforms, to view these sites as virtually one site and use one desktop (Benjamin, Aradi 
and Shreiber, 2010)—help improve global functionality of the radiological sector. Min-
imizing the burden on local sites and increasing the global nature of the images and 
information helps to standardize the practice and better identify workflow issues and 
opportunities for improvement. Additionally, implementation of such systems allows 
for global access for all referring physicians. Using SuperPACS portals, physicians are 
able to access information and have a central location and folder for their patients. This 
sort of communications technology has been reported to be cost efficient, increases re-
mote access to data, and is a logical solution to manage multiple files across multiple 
locations as the United States continues to see mergers and acquisitions throughout the 
healthcare and hospital industry (Groves et al., 2013). Unlike other technologies and 
innovations in radiology, this particular example and application places radiologists as 
some of the main stakeholders in application, increasing buy-in.  
4 Further Reforms and Opportunities in Big Data 
Applications and use cases or opens up the potential for interventions and opportunities. 
The ability to aggregate patient data has been present since the introduction of EMRs, 
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though the brunt of the healthcare industry’s capacity to analyze and manipulate these 
data has only come into play the past couple of decades. As technologies continue to 
improve and the capability of Big Data extraction expands, healthcare will see furthered 
developments involving Big Data and healthcare IT. A McKinsey analysis listed four 
categories that most, if not all, healthcare-related Big Data encompasses (Kayyali, Knott 
and Van Kuiken, 2013). As healthcare IT continues to expand, and technology increases 
consumerization, we may expect to see further varieties of Big Data.  
4.1 Retrospective Insight 
Prior to more recent years, initial applications of Big Data have focused on retrospective 
insight via retrospective data analysis. Applications and technologies were equipped to 
take large sums of data and analyze them for researchers. Previously -- and, by most, 
currently -- patient safety was studied in retrospect: clinical events were identified after 
being flagged for issues, and then analyzed to identify opportunities for improvement 
(Weinger et al., 2003)(OFIs). Reducing medical errors and safety concerns is a common 
goal of systems, and ties into many reimbursement schemas. Big Data, when applied 
retrospectively, is simply one of the parts to the pathway to reduce medical errors. Data 
must be extracted from flagged patient files and stratified to identify breakdown and 
issues in the workflow. Usually in-house committees study these and find common flaws 
that can be disseminated to medical staff in an effort to reduce future instances of work-
flow breakdown. While this approach has been the common norm for most system struc-
tures and data reporting, real-time monitoring and flagging of misuse or issues would 
likely increase safety and quality outcomes in healthcare systems.  
4.2 Predictive Power 
Pattern recognition artificial intelligence has been proposed as one of the more promis-
ing innovations for the future of radiology. Though this does not require radiologist 
stakeholders, the technology could vastly improve the efficiency and accuracy of imag-
ing. However, research is varied and inconclusive at this stage. The issue of contention 
is that, though pattern recognition can provide great promise, it requires a pseudo-cus-
tomization that makes it difficult to implement quickly across systems. In a study (Woo 
and Kim, 2017), utilization and application of US, CT, MRI technologies was shown to 
have led to an increase in the frequency of small renal masses being detected. This re-
sults in more renal cell carcinoma and benign tumor diagnosis, but no one pattern was 
found to be sufficient; rather, multiple imaging patterns should have been considered in 
tandem to then begin to narrow down remarkable images and possibly note malignancy. 
Should several imaging patterns be integrated and an algorithm created, then there could 
be a potential for widespread use of pattern recognition, hopefully leading in turn to 
faster image interpretation with less error. Though initial investments in technology 
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would be quite costly, the return on investment would be more than enough to recoup 
startup costs, as systems could reduce the amount of budget allocated to overhead costs 
(specifically: personnel) in the department. Currently, Houston Methodist Hospital em-
ploys AI technology that interprets breast x-rays 30 times faster than physicians, and 
which diagnoses with 99% accuracy (Patel et al., 2017). Though there is a fear that cur-
rent pattern recognition and the incorporation of AI will eradicate jobs among radiolo-
gists, the coexistence of human and machine is an inevitable phenomenon as automation 
increases and most studies indicate that AI is unlikely to replace radiologists 
(Krittanawong, 2017). To compensate for any possible disruption, radiologists could 
continue to subspecialize, and focus on interventions and a more technical application 
of skills, ones not yet able to be imitated by digital counterparts. 
Simultaneously, predictive power can also be applied to help detect and prevent further 
fraud, waste, and abuse. Systems use patient bills and records to analyze trends and de-
tect anomalies such as overutilization of services, discrepancy of treatment spanning 
several hospitals within a system and lack of coordination around diagnoses, and pre-
scription filling issues. For example, in implementing Big Data, the Centers for Medi-
care and Medicaid Services (CMS) prevented more than $210.7 million in healthcare 
fraud in a year (McDonald, 2017). Similarly, after transitioning to a predictive modeling 
environment, UnitedHealthCare generated a 2200% ROI after developing methodology 
to identify inaccurate claims (McDonald, 2017).  
4.3 Data Management: Population Health 
Big Data’s role in population health is not a novel application; however, its potential 
applications are great and can have a larger impact than present-day. Big Data is able to 
help providers assess and manage the risk of the populations they serve. Disease trend-
ing can allow practitioners to prioritize and strategize initiatives that are most far-reach-
ing for their populations. Community clinics, coalitions, and health fairs are becoming 
more common as health systems try to increase market share, and provide improved care 
for their patients and catchment areas.  
4.4 Direct Intervention 
Diabetes Mellitus (DM) I and II monitors, and continuous feedback loops, have been 
enabled by the application of real-time Big Data. In constantly relaying information back 
to a physician or device manufacturer, trends can be analyzed, using target values to 
indicate when insulin injections are automatically needed (Ventola, 2014). Technologies 
such as these alleviate the disease burden on the patient, allowing them to potentially 
live life with less expenditure of effort. In the case of DM patients, continuous feedback 
devices alleviate the need for the patient to rely on timekeeping values and self-injec-
tions. For younger patients (DM I), and those with anxiety and aversion to injections 
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(DM I or II), continuous feedback devices do the work for the patient and only require 
routine checkups with the physician and device manufacturer. Large aggregations of 
patient data also allow physicians to not only study individual disease trends, but also 
study trends within the patient population in general (Ventola, 2014). This enables them 
to improve practices and workflow processes. This technology is more cost-efficient 
than traditional insulin injections and physician visits. Additionally, continuous im-
provement would drastically decrease ED and physician visits as a result of unmanaged 
diabetes. Reduction in unnecessary admissions could further help drive down healthcare 
expenditures.  
Wearables, those less invasive than the continuous feedback insulin regulators, also 
show promise and hope in using patient data in order to help improve patient outcomes 
in a less invasive approach. Project DETECTED, an “intelligent bra”, is a wearable that 
is able to detect breast cancer with greater acuity than a mammography, while also re-
ducing a patient to unnecessary exposure (Ferenstein, 2012). Temperature sensors that 
screen breast tissue are able to track, record, analyze, and identify inconsistencies. These 
offer an invaluable alternative to mammographies, which have recently been found by 
multiple studies to be less accurate in detection of abnormalities in women with dense 
breast tissue. As over 40% of women currently have dense breast tissue, the inaccuracy 
leads to unnecessary biopsies and a furthering of costly technologies and surgeries. As 
systems try to consolidate costs, devices such as these offer the possibility for major cost 
savings and convenience for providers and patients.  
5 Implications for Healthcare & Big Data 
Going forward, the biggest challenge to the use of Big Data will likely be the integration 
of Big Data during the paradigm shift from FFS to value-based care. Value-based care, 
as aforementioned, is organically a more patient-centric approach. As episodes of care 
are redefined and value-based models are implemented, there will be a necessity to up-
grade reporting systems, claims processing, and process automation. Redefining these 
will lead to patient-centric improvements and outcomes as physicians, nurses, managers, 
and other healthcare employees will be encouraged to communicate and work together 
more closely. The alignment of patient and provider incentives, in addition with updated 
technology that could lead to cost transparency, will help to alleviate the current clinical 
nuance that plagues the system.  
Alleviating the clinical nuance between provider and patient will help to transform cur-
rent systems from low-value to high-value services. Current models, by contrast, pit the 
provider and patient against one another and the incentives for patients may not fit into 
standards and benchmarks set for physicians -- and vice versa. 
Patient privacy is one of the top concerns when considering the implications Big Data 
may have on a system. In light of the summer 2017 cyber-attack on England’s National 
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Health Service (NHS), additional protections and firewalls should be mandated for Big 
Data sets, especially those stored in cloud-based platforms (Gordon, Fairhall and 
Landman, 2017). Unfortunately, studies have cited low organizational vigilance, inade-
quate staffing and training, and insufficient technology investment as enablers for the 
susceptibility to healthcare data attacks. With more than 50% of hospitals reporting at 
least one ransomware attack in the past 12 months, increased budgetary allocations to-
wards intensive training and IT upgrading is an absolute necessity of health systems 
(Gordon, Fairhall and Landman, 2017). Inquiries into the cyberattacks indicated that, 
while providers had been warned about possible NHS attacks, several computer and 
processors were outdated and unable to access and download the firewalls necessary to 
prevent the ransomware attacks. While ‘Big Data methodologies’ greatly facilitate col-
lection and analysis of data, the pressure to stay abreast of security developments in the 
IT landscape poses a severe, essential challenge, given that the penalty for failing to do 
so can be no less than total data exposure (Harsh, Patil and Seshadri, no date).   
6 Conclusion 
Healthcare’s greatest challenge in the era of Big Data will be the necessity of providers 
to stay updated to change processes, especially with respect to informational security. 
Continual education and training will need to be added as security updates and techno-
logical advances become common-norm of healthcare practices. In particular, Big Data's 
storage on cloud-based applications requires a market level of protection. The Health 
Information Technology for Economic and Clinical Health (HITECH) Act was enacted 
in 2009 to extend HIPAA’s requirements to all parties that have access to protected 
health information (PHI) (‘Big Data and Health Disparities -Zhang et al., 2017), but in 
light of recent provider data breaches, more remains to be done in this area. 
As current payment reforms help to alleviate the divide between patient and provider, 
there will be a new clash—an exaggerated one—between providers and other stakehold-
ers. Owners or manufacturers of imaging technologies may use Big Data to identify 
underserved patients and disease areas. While possible to be construed as an attempt to 
provide overall improvement to population health, this initiative could exacerbate 
overutilization of healthcare, leading to an increase in provider costs. 
Such phenomena are the growing pains of paradigm shifts. Reconceiving the way pro-
viders think about the provision of care necessitates similar shifts in methodologies, 
workflows, even technologies. And this particular adjustment, this motion from 'Me' to 
'We', is one to be embraced, both for its cost-saving potential and for its intrinsic philos-
ophy of holism. Big Data methodologies construe the provider as an agent within a 
larger community or population organism, one that must adapt and change to suit the 
needs of those it serves. It allows for the provision of better care, in terms of the care 
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itself provided and the logic of its distribution. In the right hands, if Big Data is the face 
of healthcare's future, it will be a humanitarian one.  
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